$heff's $tation of $tocks & $olid DD

[BioHunter]

$QURE, $CERU

Red day took advantage of a nice ASCO play CERU near the recent offering price of $6. In at $6.15, traded as high as $9.50 last month after data update.

$QURE signed a monster deal with BMY a early April with BMY taking a stake at $33.84 per share. Stock already is priced on a likely EU hold on Glybera in May. Near term risk is CLDN, that trial is a flip of a coin at best and failure might hit other Gene Theropy companies. Huge cash reserves entered 26.42

$TTNP added .689 solid
$MEIP added $2.08 solid
$CPXX added $2.05 now full pos.

Exited $BCLI 5.10 for 18%
Exited $GBIM $9.15 for at 24%gain
$CLDN 70 covered calls expire worthless @4.40 for big gain, sold 7000 CLDN shares 16.70from $17.82 entry small loss

I am pretty sure I posted entries on the above.

Getting killed on CPXX- patience

-BioHunter